Home » Topics » BioWorld Science

BioWorld Science
RSS

Xoma poised to enter pivotal trials with Neuprex

Oct. 11, 1996

Cubist evaluating new class of antibacterial agents

Oct. 11, 1996

Daiichi discloses quinolone antibacterial agents

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

New family of marine natural products discovered

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Procter & Gamble focuses on multifunctional antibacterial agents

Oct. 11, 1996

MC-02331, a new cephalosporin with excellent activity against Gram-positive bacteria

Oct. 11, 1996

Metallo-beta-lactamase inhibitors from SKB

Oct. 11, 1996

Pivotal European trial to begin on wound-healing product from Life Medical Sciences

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
First-in-class non-β-lactam targeting AMR gram-negative pathogens
BioWorld Science
Antimicrobial resistance (AMR) is increasingly compromising the effectiveness of essential antibiotics, resulting in higher global mortality and morbidity rates....